Page 171 - Memoria SEHH 2022

MEMORIA ANUAL 2022 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GETCC
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
Publicaciones en revistas científicas
Internacionales
• Post thawing viable CD34+Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation.
Bone Marrow Transplant. 2022 Aug;57(8):1341-3. doi: 10.1038/s41409-022-01722-6. Fernández-Sojo J, Cid J, Azqueta C, Valdivia E, Martorell L, Codinach M, Marsal J, Musset- ti A, Esquirol A, Trabazo M, Benítez MI, Ferra C, Fox ML, Linares M, Alonso E, García-Rey E, García-Muñoz N, Medina L, Castillo-Flores N, Vall-Llovera F, García A, Pinacho A, Talarn C, Arroba JG, Coll R, Santos M, Valero O, Carreras E, Lozano M, Querol S .
• Robust in vitro and in vivo immunosuppressive and anti-inflammatory properties of inducible caspase-9-mediated apoptotic mesenchymal stromal/stem cell.
Stem Cells Transl Med. 2022 Mar 3;11(1):88-96. doi: 10.1093/stcltm/szab007.
Romecín PA, Vinyoles M, López-Millán B, de la Guardia RD, Atucha NM, Querol S, Bueno C, Benítez R, González-Rey E, Delgado M, Menéndez P .
• Multicenter evaluation of the IL-3-pSTAT5 assay to assess the potency of cryopre- served stem cells from cord blood units: The BEST Collaborative study.
Transfusion. 2022 Aug;62(8):1595-601. doi: 10.1111/trf.16997.
Trépanier P, Fournier D, Simard C, Fontaine MJ, Stroncek D, Takanashi M, McKenna D, Schwartz J, Tanhehco YC, Reems JA, Torrents S, Kogler G, Liedtke S, Giroux M, Holovati JL, Louis I, Prasath A, Pineault N, Bazin R; Biomedical Excellence for Safer Transfusion Collaborative .
• Leukocytapheresis variables and transit time for allogeneic cryopreserved HPC: better safe than sorry.
Bone Marrow Transplant. 2022 Oct;57(10):1531-8. doi: 10.1038/s41409-022-01750-2. Fernández-Sojo J, Horton R, Cid J, Azqueta C, García-Buendía A, Valdivia E, Martorell L, Rubio-López N, Codinach M, Aran G, Marsal J, Mussetti A, Martino R, Díaz-de-Heredia C, Ferra C, Valcárcel D, Linares M, Ancochea A, García-Rey E, García-Muñoz N, Medina L, Carreras E, Villa J, Lozano M, Gibson D, Querol S .
• Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance.
Cells. 2022 Jul 8;11(14):2153. doi: 10.3390/cells11142153.
171